Richard Whitley, MD, director of the University of Alabama at Birmingham (UAB) Division of Pediatric Infectious Diseases and a renowned researcher on antiviral therapies designed to fight infections in children and adults, has been installed as president of the Infectious Diseases Society of America (IDSA).
IDSA represents more than 9,000 physicians, scientists and other health-care professionals who specialize in infectious diseases. The society helps establish practice guidelines for the treatment and prevention of infections, promotes the development of new antimicrobials to treat drug-resistant infections and works to ensure a robust and appropriate response to public-health threats such as pandemic influenza.
Whitley is on the Advisory Council for the National Institute of Allergy and Infectious Diseases, one of the National Institutes of Health. He also is on the 2009 H1N1 Influenza Working Group of the President’s Council of Advisors on Science and Technology (PCAST). The group is providing recommendations to U.S. President Barack Obama on needed federal responses to pandemic flu.
A distinguished professor of pediatrics, microbiology, medicine and neurosurgery, Whitley is vice chair of UAB’s Department of Pediatrics and co-director of UAB’s Center for Emerging Infections and Emergency Preparedness. He will serve a one-year term with ISDA that ends November 2010.
Whitley is credited with helping to develop vidarabine, the first drug to treat encephalitis caused by the herpes simplex virus. The vidarabine breakthrough more than 30 years ago opened the door to an entire field of antiviral therapy now crucial for the treatment of influenza, human immunodeficiency virus (HIV) and other infections.
His research also is focused on using a genetically engineered version of herpes simplex virus to fight cancer. Studies show that this enhanced virus, rendered incapable of spreading the herpes virus, enters tumors and attacks cancer-cell biology to stop tumor growth.
Whitley earned his medical degree from George Washington University and completed a postdoctoral fellowship at UAB. He is the Loeb Eminent Scholar Chair in Pediatrics and an active member of the American Association of Physicians, the Society of Pediatric Research, the American Pediatric Society and other organizations.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.
CenTrak Unveils Revolutionary BLE Multi-Mode Platform for Health Care RTLS Solutions
March 22nd 2024CenTrak, the industry leader in real-time location technology, introduces the groundbreaking BLE Multi-Mode Platform, setting a new standard for Real-Time Location Systems (RTLS) in health care. Discover how this innovative solution enhances location data precision and streamlines operations for health care organizations.